B. Autran, B. Descours, V. Avettand?fenoel, and C. Rouzioux, Elite controllers as a model of functional cure, Current Opinion in HIV and AIDS, vol.6, issue.3
DOI : 10.1097/COH.0b013e328345a328

B. Walker, Elite control of HIV Infection: implications for vaccines and treatment 15:134?136. 96 3. Saez?Cirion A, Pancino G. HIV controllers: a genetically determined or inducible phenotype? 97, Top HIV Med Immunological reviews, vol.95, issue.254, pp.281-294, 2007.

E. Van-gulck, L. Bracke, L. Heyndrickx, S. Coppens, D. Atkinson et al., Immune and Viral Correlates of ???Secondary Viral Control??? after Treatment Interruption in Chronically HIV-1 Infected Patients, PLoS ONE, vol.83, issue.5, pp.37792-101, 2012.
DOI : 10.1371/journal.pone.0037792.s001

W. El?sadr, J. Lundgren, J. Neaton, F. Gordin, D. Abrams et al., CD4+ count?guided 105 interruption of antiretroviral treatment, N Engl J Med, vol.355, pp.2283-2296, 2006.

C. Danel, R. Moh, A. Minga, A. Anzian, O. Ba?gomis et al., CD4?guided structured antiretroviral 107 treatment interruption strategy in HIV?infected adults in west Africa (Trivacan ANRS 1269 trial): a 108 randomised trial, Lancet, vol.367, issue.8, 2006.

E. Rosenberg, M. Altfeld, S. Poon, M. Phillips, B. Wilkes et al., Immune control of HIV?1 110 after early treatment of acute infection, Nature, vol.407, issue.9, pp.523-526, 2000.

D. Kaufmann, M. Lichterfeld, M. Altfeld, M. Addo, M. Johnston et al., Limited Durability of Viral Control following Treated Acute HIV Infection, PLoS Medicine, vol.200, issue.2, pp.36-46, 2004.
DOI : 10.1371/journal.pmed.0010036.sd004

P. Volberding, L. Demeter, R. Bosch, E. Aga, C. Pettinelli et al., Antiretroviral therapy in acute and 114 recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment. 115, AIDS, vol.23, issue.116, p.11, 2009.

V. Wyl, S. Gianella, M. Fischer, B. Niederoest, H. Kuster et al., Early antiretroviral therapy during 117 primary HIV?1 infection results in a transient reduction of the viral setpoint upon treatment 118 interruption, PLoS One, vol.6, issue.119, pp.27463-27475, 2011.

S. Fidler, K. Porter, F. Ewings, J. Frater, G. Ramjee et al., Short?course antiretroviral therapy in 123 primary HIV infection, N Engl J Med, vol.368, issue.124, pp.207-217, 2013.

E. Hamlyn, F. Ewings, K. Porter, D. Cooper, G. Tambussi et al., Plasma HIV Viral Rebound following Protocol-Indicated Cessation of ART Commenced in Primary and Chronic HIV Infection, PLoS ONE, vol.7, issue.8, pp.43754-127, 2012.
DOI : 10.1371/journal.pone.0043754.t003

R. Steingrover, K. Pogany, F. Garcia, E. Jurriaans, S. Brinkman et al., HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy, AIDS, vol.22, issue.13, pp.1583-1588, 2008.
DOI : 10.1097/QAD.0b013e328305bd77

L. Hocqueloux, T. Prazuck, V. Avettand?fenoel, A. Lafeuillade, B. Cardon et al., Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection, AIDS, vol.24, issue.10, pp.1598-1601, 2010.
DOI : 10.1097/QAD.0b013e32833b61ba

C. Goujard, I. Girault, C. Rouzioux, C. Lecuroux, C. Deveau et al., HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy, Antiviral Therapy, vol.17, issue.6, pp.1001-1009, 2012.
DOI : 10.3851/IMP2273

S. Lodi, L. Meyer, A. Kelleher, M. Rosinska, J. Ghosn et al., Immunovirologic control 24 months 137 after interruption of antiretroviral therapy initiated close to HIV seroconversion, Arch Intern Med, vol.138, issue.139, pp.1721252-1255, 2012.

J. Siliciano, J. Kajdas, D. Finzi, T. Quinn, K. Chadwick et al., Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells, Nature Medicine, vol.9, issue.6, pp.727-728, 2003.
DOI : 10.1038/nm880

S. Lewin and C. Rouzioux, HIV cure and eradication: how will we get from the laboratory to effective clinical trials?, AIDS, vol.25, issue.7, pp.885-897, 2011.
DOI : 10.1097/QAD.0b013e3283467041

J. Routy, M. Boulassel, C. Nicolette, and J. Jacobson, Assessing risk of a short-term antiretroviral therapy discontinuation as a read-out of viral control in immune-based therapy, Journal of Medical Virology, vol.3, issue.6, pp.885-889, 2012.
DOI : 10.1002/jmv.23297

C. Machado, M. Rios?villegas, J. Galvez?acebal, A. Dominguez?castellano, F. Fernandez?cuenca et al., Long-term outcome of patients after a single interruption of antiretroviral therapy: a cohort study, BMC Research Notes, vol.5, issue.1, p.578, 2012.
DOI : 10.1086/432881